Fenofibrate Therapy in Carnitine Palmitoyl Transferase Type 2 Deficiency

Table 1

Change in lipid levels with therapy.

Months	Lipid therapy (mg/d)	TC*	TG*	HDL-C*	LDL-C*
0	Nil	7.4	1.5	1.5	4.4
1	Nil	7.1	1.4	1.6	4.3
4	Rosuvastatin 5 mg	4.9	1.1	1.5	2.5
7	Fenofibrate 145 mg + ezetimibe 10 mg	5.0	0.8	1.6	2.35
11	Fenofibrate 145 mg	5.9	1.0	1.7	3.1
17	Fenofibrate 145 mg	5.4	1.5	1.3	3.4
19	Fenofibrate 145 mg	5.0	0.8	1.6	2.35
22	Fenofibrate 145 mg	5.9	1.0	1.7	3.1
28	Nil	7.6	3.7	1.3	4.8
30	Nil	7.4	1.7	1.4	4.8
31	Nil	7.9	1.8	1.2	5.2
33	Fenofibrate 96 mg	6.1	1.5	1.6	3.4

*TC: total cholesterol, TG: triglycerides, HDL-C: high density lipoprotein cholesterol, LDL-C: low density lipoprotein cholesterol (mmol/L).